anmelden
Swiss All Share Index
19.854,81
PKT
+24,74
PKT
+0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.10.12 | UBS neutral | Exane-BNP Paribas SA | |
| 15.10.12 | Nestlé outperform | Cheuvreux SA | |
| 15.10.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 15.10.12 | Givaudan hold | Vontobel Research | |
| 15.10.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 15.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 15.10.12 | Clariant buy | Sarasin Research | |
| 15.10.12 | Clariant buy | Vontobel Research | |
| 15.10.12 | Sulzer buy | Vontobel Research | |
| 15.10.12 | Swiss Life neutral | Goldman Sachs Group Inc. | |
| 12.10.12 | Novartis outperform | Credit Suisse Group | |
| 12.10.12 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 12.10.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 12.10.12 | Novartis buy | Nomura | |
| 12.10.12 | Sulzer buy | Vontobel Research | |
| 12.10.12 | SGS SA buy | Vontobel Research | |
| 12.10.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 12.10.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 12.10.12 | UBS outperform | Credit Suisse Group | |
| 12.10.12 | Novartis reduce | Vontobel Research | |
| 12.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 12.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 12.10.12 | Sulzer buy | Sarasin Research | |
| 12.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 11.10.12 | Novartis buy | Deutsche Bank AG | |
| 11.10.12 | Novartis buy | UBS AG | |
| 11.10.12 | Swisscom neutral | Nomura | |
| 11.10.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 11.10.12 | Nestlé overweight | Morgan Stanley | |
| 11.10.12 | Kühne + Nagel International hold | Vontobel Research | |
| 11.10.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 11.10.12 | EMS-CHEMIE hold | Vontobel Research | |
| 10.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 10.10.12 | Swatch (I) outperform | Credit Suisse Group | |
| 10.10.12 | Nestlé neutral | UBS AG | |
| 10.10.12 | Richemont neutral | Credit Suisse Group | |
| 10.10.12 | Kühne + Nagel International underperform | Cheuvreux SA | |
| 10.10.12 | Sulzer outperform | Cheuvreux SA | |
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA |